TG Therapeutics: Q3 Earnings Snapshot

MORRISVILLE, N.C. (AP) — MORRISVILLE, N.C. (AP) — TG Therapeutics Inc. (TGTX) on Monday reported third-quarter earnings of $55.5 million.

On a per-share basis, the Morrisville, North Carolina-based company said it had net income of 35 cents.

The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 28 cents per share.

The biopharmaceutical company posted revenue of $259.9 million in the period, which also topped Street forecasts. Three analysts surveyed by Zacks expected $247.2 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TGTX at https://www.zacks.com/ap/TGTX